Probiotic supplementation in multiple sclerosis - Trial IRCT20220713055465N1
Access comprehensive clinical trial information for IRCT20220713055465N1 through Pure Global AI's free database. This Phase 2 trial is sponsored by Tabriz University of Medical Sciences and is currently Recruiting. The study focuses on Multiple sclerosis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT20220713055465N1
Phase 2
Recruiting
biological
Trial Details
Iranian Registry Of Clinical Trial • IRCT20220713055465N1
Probiotic supplementation in multiple sclerosis
The effects of probiotics in functional abilities of multiple sclerosis patients: a randomized double-blind placebo-control trial
Study Focus
Sponsor & Location
Tabriz University of Medical Sciences
Iran
Timeline & Enrollment
Phase 2
Aug 23, 2022
N/A
ICD-10 Classifications
Multiple sclerosis
Progressive systemic sclerosis
Systemic sclerosis
Systemic sclerosis, unspecified
Diffuse sclerosis
Data Source
Iranian Registry Of Clinical Trial
IRCT20220713055465N1
Non-Device Trial